/ 20 Shares
06-Sep-2023 - 08-Sep-2023
₹ 695 - ₹ 735
₹ 14700.00
20
11,824,163
Face Value - ₹ 10/- Per Share
Listing at NSE BSE
206,922 Application Required in Retail for 1 Time.
Registrar : KFin Technologies Limited
Fresh Issue of Equity Shares aggregating upto ?615 Crore and Offer for Sale of upto 4,450,000 Equity Shares
Category | % | Shares/Amount |
---|---|---|
QIB | 50% | 5,912,080 Shares Rs. 434.54 Cr |
HNI 1 | 5% | 591,209 Shares Rs. 43.25 Cr @ 2111 Form 1x |
HNI 2 | 10% | 1,182,416 Shares Rs. 86.91 Cr @ 4223 Form 1x |
Retail | 35% | 4,138,458 Shares Rs. 304.18 Cr @ 206923 Form 1x |
ICICI Securities, Nuvama Wealth, JM Financial
Retail (Upto 2 Lakh) | HNI (2 Lakh to 10 Lakh) | HNI (Above 10 Lakh) |
---|---|---|
206923 Form 1x | 2111 Form 1x | 4223 Form 1x |
Category | Lots | Shares | Amount |
---|---|---|---|
Retail (Upto 2 Lakh) | 1 | 20 | ₹ 14,700 |
Retail (Upto 2 Lakh) | 13 | 260 | ₹ 191,100 |
S-HNI (2 Lakh to 10 Lakh) | 14 | 280 | ₹ 205,800 |
S-HNI (2 Lakh to 10 Lakh) | 68 | 1360 | ₹ 999,600 |
B-HNI (Above 10 Lakh) | 69 | 1380 | ₹ 1,014,300 |
08-Sep-2023 17:01
Category | Book Size | Subscription | No. of Times |
---|---|---|---|
QIB | 2,364,832 ₹ 173.82 Cr. | 444,494,800 ₹ 32670.37 Cr. | 187.96x |
HNI (<10 LAKH) | 591,209 ₹ 43.45 Cr. | 15,785,100 ₹ 1160.20 Cr. | 26.70x |
HNI2 (>10 LAKH) | 1,182,416 ₹ 86.91 Cr. | 48,057,860 ₹ 3532.25 Cr. | 40.64x |
RETAIL | 4,138,458 ₹ 304.18 Cr. | 33,068,100 ₹ 2430.51 Cr. | 7.99x |
Total | 8,276,915 | 541,405,860 | 65.41x |
Category | Book Size | Subscription | No. of Times |
---|---|---|---|
QIB | 2,364,832 ₹ 173.82 Cr. | 444,494,800 ₹ 32670.37 Cr. | 187.96x |
HNI (<10 LAKH) | 591,209 ₹ 43.45 Cr. | 15,785,100 ₹ 1160.20 Cr. | 26.70x |
HNI2 (>10 LAKH) | 1,182,416 ₹ 86.91 Cr. | 48,057,860 ₹ 3532.25 Cr. | 40.64x |
RETAIL | 4,138,458 ₹ 304.18 Cr. | 33,068,100 ₹ 2430.51 Cr. | 7.99x |
Total | 8,276,915 | 541,405,860 | 65.41x |
*Excluding Anchor
Total No. of Application Approx : ~1427750 (6.90 Appwise)
Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.
They have been operating for over 15 years as a corporate quaternary care healthcare service provider in densely populated micro markets in the western regions of India and currently operate 3 hospitals under the “Jupiter” brand in Thane, Pune and Indore, with an operational bed capacity (i.e. census and non-census beds) of 950 beds and 1,306 doctors including specialists, physicians and surgeons, as of March 31, 2023. The current operational bed capacity is 961 beds.
They have equipped their hospitals with over 30 specialties, as of March 31, 2023, including key specialties of organ transplant, oncology, orthopaedics, cardiology, paediatrics, neurology, and neurosurgery as well as certain specialised quaternary services and precision-based treatments such as brachytherapy, radiotherapy, robotic knee replacement and robotic neuro rehabilitation.
JLHL commenced operations in 2007 with their hospital in Thane, Maharashtra and subsequently scaled their operations by setting up a hospital in Pune, Maharashtra in 2017 and acquiring a hospital in Indore, Madhya Pradesh in 2020
Each of their hospitals at Thane, Pune and Indore has been certified by the National Accreditation Board for Hospitals & Healthcare Providers (“NABH”) and has been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (“NABL”).
Their hospitals function on an ‘all-hub-no-spoke’ model with each hospital being a full-service hospital, operating independently and serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. Their Thane and Pune hospitals are “greenfield” projects, and all 3 of their hospitals are located on land owned by them on a freehold basis.
They are also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has recently commenced construction in April 2023.
Dr Ajay Thakker is the Promoter, Chairman and Managing Director of the company. Dr Ankit Thakker is the Promoter, Executive Director, and Chief Executive Officer of the company. Dr Bhaskar Shah is a Non-Executive Director of the company. Vadapatra Raghavan is a Non-Executive Director of the Company. Dr Darshan Vora is an Independent Director of the company. Dr Jasmin Patel is an Independent Director of the Board of the company. Satish Utekar is an Independent Director of the company. Urm
Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
Assets | 788.91 | 908.70 | 985.53 |
Revenue | 490.27 | 737.14 | 902.96 |
Profit After Tax | -2.30 | 51.13 | 72.91 |
Net Worth | 246.44 | 288.43 | 363.91 |
Reserves and Surplus | |||
Total Borrowing | 425.52 | 495.25 | 468.63 |
Amount in ? Crore
Once you create your account, Login to Us.
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Enter your UPI ID and you will receive mandate on your UPI App.
Once you accept the mandate, Application is submitted successful.